Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 494
Immune Disorders Drugs 208
Drug Discovery 169
Cardiovascular Drugs 165
Infectious Diseases Drugs 140
Biopharmaceuticals 131
Clinical Trials 128
Endocrine and Metabolic Disorders Drugs 113
Central Nervous System Drugs 107
Musculoskeletal Disorders Drugs 102
Pharmaceuticals 99
Hematological Drugs 85
Leukemia Drugs 84
Liver and Kidney Disorders Drugs 79
Lymphoma Drugs 64
Dermatological Drugs 59
Diabetes Drugs 57
Brain Cancer Drugs 50
Skin Cancer Drugs 50
Respiratory Drugs 45
Mental Disorders Drugs 44
Gastrointestinal Drugs 43
Lung Cancer Drugs 41
Drug Delivery 39
Pharmaceutical Intermediates 36
Immunosuppressive Drugs 36
Pharmaceutical Manufacturing 33
Liver Cancer Drugs 30
Infusions and Injectables 30
Analgesics 27
Bladder Cancer Drugs 26
Antibiotics 26
Drugs by Therapeutic Area 25
Kidney Cancer Drugs 22
HIV/AIDS Drugs 21
Colon Cancer Drugs 20
Pancreatic Cancer Drugs 20
Prostate Cancer Drugs 18
Urological Disorders Drugs 18
Schizophrenia Drugs 17
Ovarian Cancer Drugs 16
Cervical Cancer Drugs 16
Sexual and Reproductive Health Drugs 16
Breast Cancer Drugs 14
Cancer Vaccines 14
Thyroid Cancer Drugs 14
Psoriasis Drugs 14
Over the Counter (OTC) Drugs 11
Biosimilars and Biosuperiors 11
Generic Drugs 10
Vaccines 10
Anti-Obesity Drugs 9
Optical Disorders Drugs 8
Transdermal and Transmucosal Drug Delivery 8
Alzheimer's Disease Drugs 8
Uterine Cancer Drugs 6
Company Reports 5
Pharmacoeconomics 5
Cough and Cold Drugs 5
Anxiety Drugs 4
Vitamins and Dietary Supplements 3
Asthma Drugs 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Allergy Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



273 reviews

2,539 Results (Page 70 of 127)
- Relevance
  Sort by

Idiopathic Pulmonary Fibrosis Market by Therapeutic Class, Route of Administration, Distribution Channel, End User - Global Forecast to 2030

 Report
May 2025
193 Pages
Global

From

€3117EUR$3,545USD£2,692GBP

€3463EUR$3,939USD£2,991GBP

CXCR4 Receptor Antagonists - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1319EUR$1,500USD£1,139GBP

Human Microbiome Market: Focus on Therapeutics, Diagnostics and Fecal Microbiota Therapy: Distribution by Type of Molecule, Type of Product, Target Indication, Therapeutic Areas, Supply Channels and Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035

 Report
April 2022
552 Pages
Global

From

€4220EUR$4,799USD£3,644GBP

Pelvic Inflammatory Disease Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
116 Pages
Global

From

€4177EUR$4,750USD£3,607GBP

Dermatological Drugs Market 2024-2028

 Report
July 2024
139 Pages
Global

From

€2198EUR$2,500USD£1,898GBP

NEED HELP FINDING THE RIGHT PRODUCT? Eman will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Heart Failure Drugs - Global Strategic Business Report

 Report
July 2025
179 Pages
Global

From

€5144EUR$5,850USD£4,442GBP

Heparin - Global Strategic Business Report

 Report
July 2025
184 Pages
Global

From

€5144EUR$5,850USD£4,442GBP

Vasculitis Treatment - Global Strategic Business Report

 Report
July 2025
183 Pages
Global

From

€5144EUR$5,850USD£4,442GBP

Cardiovascular Drugs - Global Strategic Business Report

 Report
July 2025
413 Pages
Global

From

€5144EUR$5,850USD£4,442GBP

Dyslipidemia Drugs - Global Strategic Business Report

 Report
July 2025
268 Pages
Global

From

€5144EUR$5,850USD£4,442GBP

Atherosclerosis Therapeutics - Global Strategic Business Report

 Report
July 2025
181 Pages
Global

From

€5144EUR$5,850USD£4,442GBP

Benign Prostatic Hyperplasia Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2024
97 Pages
Global

From

€3500EUR$4,264USD£3,128GBP

Australia and New Zealand Cutaneous T-cell Lymphoma Market Report and Forecast 2024-2032

 Report
February 2024
120 Pages
New Zealand, Australia New Zealand, Australia

From

€2452EUR$2,789USD£2,118GBP

High Potency APIs/HPAPI Market by Type (Innovative, Generic), Type of Synthesis (Synthetic, Biotech, Biosimilars, mAbs, Vaccines), Manufacturers (Captive, Merchant), Application (Oncology, Hormonal Imbalance, Glaucoma), and Region - Forecast to 2027

 Report
May 2022
270 Pages
Global

From

€4352EUR$4,950USD£3,759GBP

Myeloid Cells Targeting Therapeutics Market by Type of Molecule (Small Molecule and Biologics), Therapeutic Area (Oncological Disorders and Rare Disorders), Route of Administration (Intravenous and Oral) and Geography (North America, Europe and Asia Pacific), 2021-2035

 Report
January 2022
212 Pages
Global

From

€4220EUR$4,799USD£3,644GBP

Pediatric Clinical Trials - Global Strategic Business Report

 Report
July 2025
389 Pages
Global

From

€5144EUR$5,850USD£4,442GBP

Omics-based Clinical Trials - Global Strategic Business Report

 Report
July 2025
176 Pages
Global

From

€5144EUR$5,850USD£4,442GBP

Prostate Cancer Diagnosis and Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
July 2024
105 Pages
Global

From

€3500EUR$4,264USD£3,128GBP

T-Cell Acute Lymphoblastic Leukemia - Pipeline Insight, 2025

 Drug Pipelines
April 2025
60 Pages
Global

From

€1319EUR$1,500USD£1,139GBP

Alzheimer's Disease: Pipeline Review, Developer Landscape and Competitive Insights

 Report
March 2019
220 Pages
Global

From

€2637EUR$2,999USD£2,277GBP

2,539 Results (Page 70 of 127)
- 1
- 68
- 69
- 70
- 71
- 72

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.